Noticias de IMMP_US

Noticias del mercado

Últimas noticias sobre IMMP_US — 93 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: IMMP_US ✕ 93 resultados
16/03/2026 IMMP_US — Meyka
Immutep (IMM.AX) drops to A$0.061 16 Mar 2026: heavy volume signals reprice
14/03/2026 IMMP_US — Medical Dialogues
Dr Reddy's Partner Immutep Halts Phase III Trial of Eftilagimod Alfa in Lung Cancer Study
13/03/2026 IMMP_US — Quiver Quantitative
Immutep Limited Announces Discontinuation of Phase III TACTI-004 Trial Following IDMC Futility Analysis
13/03/2026 IMMP_US — Investing.com
Citizens downgrades Immutep stock rating on lead program halt
13/03/2026 IMMP_US — Seeking Alpha
Immutep downgraded after late-stage trial setback for lead drug
13/03/2026 IMMP_US — Benzinga
Immutep Stock Sinks To 52-Week Low - Here's Why - Immutep (NASDAQ:IMMP)
13/03/2026 IMMP_US — GlobeNewswire
TACTI-004 Phase III Study in First Line NSCLC to be discontinued following Futility Analysis
13/03/2026 IMMP_US — Investing.com
Baird cuts Immutep stock rating on trial discontinuation
13/03/2026 IMMP_US — Stock Titan ES ← OM
Dr. A.S. El socio de Reddy (NYSE: RDY) detiene el ensayo de fase III de eftilagimod alfa TACTI-004
13/03/2026 IMMP_US — Investing.com UK
Citizens downgrades Immutep stock rating on lead program halt By Investing.com
13/03/2026 IMMP_US — Investing.com UK
Immutep stock plunges 80% after lung cancer trial halted By Investing.com
13/03/2026 IMMP_US — MEXC
Immutep (IMMP) Stock Crashes 80% After Phase III Lung Cancer Trial Halted on Efficacy Grounds
13/03/2026 IMMP_US — MEXC
Immutep (IMMP) Stock Plummets 80% Following Phase III Lung Cancer Study Termination
13/03/2026 IMMP_US — Kalkine Media
ASX 200 Watch: What Immutep’s Efti Trial Shift Means Now
13/03/2026 IMMP_US — Kalkine Media
Immutep Halts Key Lung Cancer Trial, Refocuses Strategy
12/03/2026 IMMP_US — TipRanks
Immutep Halts Pivotal Lung Cancer Trial After Futility Review
12/03/2026 IMMP_US — DirectorsTalk Interviews
Immutep Limited (IMMP) Investor Outlook: Biotech Firm's Promising Pipeline Offers 244% Potential Upside
12/03/2026 IMMP_US — TipRanks
Immutep Trading Resumes on ASX After Key Phase III Trial Update
12/03/2026 IMMP_US — marketscreener.com
Immutep says TACTI-004 to be discontinued following futility analysis
10/03/2026 IMMP_US — TipRanks
Immutep Shares Suspended Pending Key Phase III Trial Futility Update

Página 4 de 5

keyboard_arrow_up